Plain-English translation of NCT05543798 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Vision-MR Ablation Catheter 2.0, a specialized tube inserted into the heart to treat ventricular tachycardia — a dangerous irregular heartbeat that can occur after a heart attack. The catheter uses radiofrequency energy (similar to microwave heat) to safely destroy the heart tissue causing the abnormal rhythm. This procedure is performed while guided by real-time MRI imaging, which may help doctors see the heart more clearly during treatment.
Many people with dangerous irregular heartbeats don't respond well to heart rhythm medications, or they can't tolerate those drugs. This trial exists to see whether using this new imaging-guided catheter tool can safely and effectively eliminate these life-threatening rhythms and improve patients' outcomes.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo a catheter ablation procedure guided by real-time MRI imaging. A thin tube (catheter) is threaded through a blood vessel to your heart, where it delivers radiofrequency energy to destroy the tissue causing your irregular heartbeats. The procedure is performed in a specialized cardiac center and may involve pre-procedure testing and imaging. After the procedure, you will be monitored to ensure the treatment was successful and that you recover well.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Germany
Netherlands
Sponsor
Imricor Medical Systems
Enrollment target
~64 participants
Started
April 2025
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kate Lindborg, Phd
Imricor Medical Systems
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.